Nav: Home

Health indicators for newborns of breast cancer survivors may vary by cancer type

February 05, 2018

CHAPEL HILL -- For breast cancer survivors, the risk of giving birth prematurely, and for other health concerns for their newborns, may depend on the type of breast cancer they had, according to a study from University of North Carolina Lineberger Comprehensive Cancer Center researchers.

In a study published in the International Journal of Cancer, researchers analyzed health indicators for children born to young breast cancer survivors in North Carolina. This included evaluating whether newborns were born preterm (less than 37 weeks), if they were below normal weight, small for gestational age, or if they were born through a Cesarean delivery. Overall, there was not an increase in the prevalence of preterm birth, C-section, small for gestational age, or low birth weight for newborns across all breast cancer types.

"We're focusing on these outcomes because we know that child development in utero is important, and every week matters," said UNC Lineberger's Hazel B. Nichols, PhD, assistant professor in the UNC Gillings School of Global Public Health.

However, when they examined the data by breast cancer type, researchers found increased risk of preterm birth, low birth weight, and C-section delivery for women with estrogen receptor-negative breast cancer. Researchers cautioned that further studies are needed to confirm the finding.

"The good news is that overall, women who conceived after their breast cancer diagnosis did not have an increased risk of preterm birth," Nichols said. "However, when we looked more closely, we saw that women with estrogen receptor-positive breast cancer didn't have an increased risk of preterm birth, but women with estrogen receptor-negative breast cancer did--and it was almost twice as high. What we need to do next is to see if this same finding is replicated in larger studies."

As survival rates for breast cancer improve, more women face questions about their lives after cancer, including about their plans to start, or complete, their families. Studies from Canada and Europe have found there is a lower incidence of childbirth for breast cancer survivors compared to women of the same age in the general population. Previous studies have pointed to higher risks of low birth weight and preterm deliveries compared to women without breast cancer. However, these risks have not been examined by breast cancer type, the researchers said.

"This study is one piece of a larger effort to understand the needs of women with breast cancer beyond their cancer treatment," Nichols said. "A breast cancer diagnosis can impact a lot of different aspects of your life, and building a family is one of them. Increasingly, research is focused on providing answers for those long-term questions that women have. "

The study used N.C. Central Cancer Registry data to analyze the cases of 4,978 women diagnosed with breast cancer in North Carolina between 2000 and 2013. For the group overall, they found no significant difference in the prevalence of pre-term birth, low birth weight, and other measures between women with or without breast cancer. But for women with estrogen receptor-negative breast cancer, 18 percent of births were preterm. That compares to a rate of about 10 percent of all births in North Carolina that are preterm, Nichols said. She cautioned that they need to ensure this is a real finding by examining a larger number of patients.

"Fewer women have estrogen receptor negative breast cancer, so our results were based on a small number of women," Nichols said. "What we need to do next is to see if the same pattern is seen in other studies as well."

Analyzing the number of live births to women that occurred after their diagnosis, they found that about 8 percent of those women had had at least one child by 10 years after their diagnosis.

Compared to the general population, the birth rate for women with breast cancer in the study was about 57 percent lower than for women who did not have breast cancer, Nichols said. Births were less common in women who received chemotherapy, and in women who had breast cancer at more advanced stages.

And while researchers found that women with estrogen receptor-negative breast cancer were initially more likely to have children after their breast cancer diagnosis than were women with estrogen-receptor positive breast cancer, the proportion of women who went on to have children (about 10 percent) was similar in both groups 10 years after diagnosis.

Researchers say this difference could be attributed to treatment for estrogen receptor-positive breast cancer. These treatments, which target estrogen, are recommended to be taken at least 5 years to prevent cancer recurrence. A clinical trial at UNC Lineberger and other centers is investigating whether endocrine therapy can be safely interrupted to allow women to conceive during this period.

"Though women who have estrogen receptor-positive breast cancer are less likely to have a child in the first five years following their diagnosis, they do catch up by 10 years," Nichols said. "We're seeing lower births during the time period when they're most likely to be taking endocrine therapy."

The researchers also plan to survey young women with breast cancer later this year to probe possible explanations for the lower birth rate among breast cancer survivors. They hope to determine if it is a side effect of treatment or whether the women chose not to become pregnant. They also intend in a future study to evaluate whether preterm birth affects later outcomes for the child's health.

Nichols said that the study's findings reinforced that fertility counseling is important for breast cancer patients who may want to have children.

"There are very consistent recommendations that women who are diagnosed with breast cancer should be counseled before they're treated about any potential risks of their cancer treatment on future fertility," Nichols said. "I think we need to do a better job making sure all women with cancer get the information they need before they start their treatment."
-end-
In addition to Nichols, other authors include Chelsea Anderson, doctoral student in the UNC Gillings School of Global Public Health Department of Epidemiology, Stephanie M. Engel, PhD, an associate professor in the Gillings School, and Carey Anders, MD, UNC Lineberger member, medical director of the UNC Breast Center, and associate professor in the UNC School of Medicine Division of Hematology/Oncology.

The study was funded by the National Cancer Institute and the National Center for Advancing Translational Sciences.

UNC Lineberger Comprehensive Cancer Center

Related Breast Cancer Articles:

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.
Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
More Breast Cancer News and Breast Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.